GREEN LIFESCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,997 KRW | +0.15% |
|
-0.65% | -10.25% |
| 07/05 | Green Lifescience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 06/03 | Green Lifescience Co., Ltd.'s Equity Buyback Plan Extended till September 6, 2024. | CI |
| Sales 2022 | 36.5B 26.32M 2.2B | Sales 2023 | 22.37B 16.13M 1.35B | Capitalization | 44.5B 32.08M 2.68B |
|---|---|---|---|---|---|
| Net income 2022 | -3.53B -2.54M -212M | Net income 2023 | -16.36B -11.79M -985M | EV / Sales 2022 | 2.15 x |
| Net cash position 2022 | 10.32B 7.44M 622M | Net cash position 2023 | 9.52B 6.86M 573M | EV / Sales 2023 | 1.56 x |
| P/E ratio 2022 |
-25.2
x | P/E ratio 2023 |
-2.72
x | Employees | 70 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 70.56% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.15% | ||
| 1 week | -0.65% | ||
| Current month | -0.65% | ||
| 1 month | -4.68% | ||
| 3 months | -12.22% | ||
| 6 months | -9.23% | ||
| Current year | -10.25% |
1 week
1 973.00
2 040.00
1 month
1 960.002 220.00
Current year
1 817.002 475.00
1 year
1 781.002 850.00
3 years
1 781.009 525.00
5 years
1 781.0025 500.00
10 years
1 781.0025 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Gi-Seong Lee
CEO | Chief Executive Officer | 59 | - |
Joon-Hwa Yang
CEO | Chief Executive Officer | 53 | 24/22/24 |
Jae-Hang Park
AUD | Comptroller/Controller/Auditor | 51 | 01/16/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Joon-Hwa Yang
CEO | Chief Executive Officer | 53 | 24/22/24 |
Gi-Seong Lee
CEO | Chief Executive Officer | 59 | - |
Jeong-Ki Hong
BRD | Director/Board Member | 53 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/24/21 | 1,997 | +0.15% | 7,658 |
| 20/24/20 | 1,994 | +0.20% | 12,584 |
| 19/24/19 | 1,990 | -0.50% | 10,355 |
| 18/24/18 | 2,000 | +0.05% | 15,394 |
| 17/24/17 | 1,999 | -0.55% | 9,831 |
End-of-day quote Korea S.E., June 21, 2024
More quotes
Green LifeScience Co Ltd, formerly KPX Lifescience Co Ltd, is a Korea-based company that mainly manufactures raw materials and intermediates for pharmaceuticals and pesticides. The Companyâs products consist of AMZ, which is used as crop protection materials; TAZD, which is used as a herbicide intermediate; D003M and T003M, which is used as artificial marble additives, as well as PM04, which is used as a pharmaceutical intermediate. The Company also provides antibiotics and others. The Company distributes its products within domestic market and to overseas markets, including Japan, the United States, Europe and others.
Sector
Pharmaceuticals
Calendar
14/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -10.25% | 28.73M | |
| +16.50% | 42.12B | |
| +20.78% | 21.72B | |
| +21.14% | 15.75B | |
| +23.69% | 14.89B | |
| +57.44% | 13.06B | |
| -0.05% | 6.79B | |
| -14.94% | 6.3B | |
| +20.03% | 6.05B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- A114450 Stock
